US Broker Ratings

Akebia Therapeutics (AKBA): A Potential 272% Upside in the Healthcare Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands out in the healthcare sector with an intriguing investment proposition for individual investors. With a market capitalization of $384.78 million, Akebia is carving a..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring the 80.89% Potential Upside

Ardelyx, Inc. (NASDAQ: ARDX) stands out in the biotechnology sector with a compelling growth narrative and a promising 80.89% potential upside, as suggested by analyst target prices. As a company..

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Exploring a Potential 115% Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a late-stage biotechnology firm, is making waves in the healthcare sector with its innovative gene therapy programs targeting rare and devastating diseases. Headquartered in Cranbury,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Evaluating the Healthcare Innovator’s Growth Potential

Avanos Medical, Inc. (NYSE: AVNS), a distinguished player in the healthcare sector, operates within the dynamic medical devices industry. With a market capitalization of approximately $598.34 million, this Alpharetta, Georgia-based..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Strong Buy Ratings and Nearly 100% Upside Potential

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, Trevi is focused on the development..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A Biotech Gem with 21.98% Upside Potential

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is garnering significant attention in the healthcare sector. With a market capitalization of $2.31 billion, the New York-based company focuses on..

Inventiva S.A. (IVA): Unpacking the 145% Upside Potential in Biotech’s Promising Contender

Inventiva S.A. (NASDAQ: IVA), a French biopharmaceutical company, is garnering significant attention in the biotechnology sector. With a market capitalization of $1.21 billion, the company is making waves primarily due..

Precigen, Inc. (PGEN) Stock Analysis: 87% Upside Potential Ignites Investor Interest

Precigen, Inc. (NASDAQ: PGEN) is capturing the attention of investors with a compelling 87.64% potential upside, as indicated by its average target price. This biopharmaceutical company, specializing in gene and..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 111.97% Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a leader in regenerative medicine, is capturing investor attention with its impressive growth potential. With a market cap of $508.92 million, this U.S.-based company operates..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Eyeing a 119% Upside with a Strong Buy Consensus

Gyre Therapeutics, Inc. (GYRE) stands out in the biotechnology sector with a compelling story for growth-oriented investors. Headquartered in San Diego, California, this pharmaceutical company is making waves in the..

SI-BONE, Inc. (SIBN) Stock Analysis: Aiming for a 53% Upside With Innovative Medical Solutions

SI-BONE, Inc. (NASDAQ: SIBN) is making waves in the healthcare sector, specifically in the medical devices industry. Known for its innovative approach to addressing musculoskeletal disorders, the company has positioned..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: A Healthcare Play with Robust Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the U.S. medical care facilities sector, has garnered attention with its robust 25.90% revenue growth. Based in Dallas, Texas, this company,..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 277% Upside Potential in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) commands attention in the biotechnology sector with its innovative approach to drug discovery and development, leveraging its proprietary GEODe technology platform. With a current market..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Potential Upside Amidst Volatile Valuation

Investors with an eye on the biotechnology sector may find Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) a curious case study. With a market cap of $564.09 million, Ginkgo operates in..

AbCellera Biologics Inc. (ABCL) Investor Outlook: Unveiling a Potential 154.75% Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology firm, is making waves in the healthcare sector with its innovative approach to antibody drug discovery. At its current price of $3.86,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech’s Promising Prospects with 5.7% Upside Potential

Sionna Therapeutics, Inc. (NASDAQ: SION) is making waves in the healthcare sector, specifically within the biotechnology industry, as it seeks to revolutionize the treatment of cystic fibrosis (CF). With a..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A Biotech Powerhouse with 34.79% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology arena, with its focus on precision therapies for genetically defined diseases. Headquartered in Waltham, Massachusetts, Cogent is carving out..

Akso Health Group (AHG) Stock Analysis: Exploring the 415.8% Revenue Surge and Its Implications for Investors

Akso Health Group (NASDAQ: AHG), a dynamic player in the healthcare sector, is garnering attention with its remarkable 415.8% revenue growth. This surge raises important considerations for investors keen on..

Semler Scientific, Inc. (SMLR): Investor Outlook on a 258% Potential Upside in the Healthcare Sector

Semler Scientific, Inc. (NASDAQ: SMLR) has captured investor attention with a remarkable potential upside of 258.65%, as indicated by current analyst ratings. Despite the healthcare sector’s notorious volatility, this figure..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotech Sector with Strategic Collaborations

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the biotechnology sector, is capturing attention with its strategic partnerships and service offerings in clinical development. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds